Safety of low intensity oral anticoagulant therapy in patients with bileaflet mechanical aortic valve prosthesis: A propensity weighted study - ScienceDirect
PROACT Xa Trial: Mechanical Valve Replacement Without Warfarin
Why ON-X - Heart Valve Choice
On-X Life Technologies Reports CE Mark Approval to Sell Its Mechanical Aortic Heart Valve with an Expanded Labeling Claim: a Reduction in the Required Use of Blood Thinners | Business Wire
Heart valve disease module 7: anti-thrombotic therapy for valvular heart disease - The British Journal of Cardiology
How to bridge? Management of anticoagulation in patients with mechanical heart valves undergoing noncardiac surgical procedures - The Journal of Thoracic and Cardiovascular Surgery
83 Valvular heart disease, anticoagulation, TAVR, and primary care - The Curbsiders
Anticoagulation: Focus on DOACs and Reversal - ppt download
pressure gradients of On-X mechanical valves in aortic and mitral posi-... | Download Scientific Diagram
Prosthetic valve thrombosis: Time is critical - Mayo Clinic
Antithrombotic Therapy in Patients with Prosthetic ... | GrepMed
Low-dose anticoagulation after isolated mechanical aortic valve replacement with Liva Nova Bicarbon prosthesis: A post hoc analysis of LOWERING-IT Trial | Scientific Reports
Antithrombotic Therapy in Patients With Valvular Heart Disease
Rationale and design of PROACT Xa: A randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in patients with a mechanical On-X Aortic Heart Valve -
Antithrombotic therapies in patients with prosthetic heart valves: guidelines translated for the clinician. - Abstract - Europe PMC
Chris McAloon ar Twitter: "ESC 2012 Guidelines on Target INR for Mechanical Valves (note types of valve & risk factors) #CardioEd #EEGC https://t.co/wpbVk30frW https://t.co/NqUjRIqdVu" / Twitter